Searchable abstracts of presentations at key conferences in endocrinology

ea0073aep695 | Thyroid | ECE2021

-Systemic erdheim-chester disease associated with braf-positive papillary thyroid carcinoma

Ilie Iuliana , Francois Emile Jean , Chereau Natalie , Haroche Julien , Buffet Camille , Deniziaut Gabrielle , Constantin Teodor , Bercu Bogdan , Oprea Luciana , Banica Andreea , Musat Madalina

Erdheim-Chester disease (ECD) is a rare histiocytic neoplasm with distinctive clinical and immunophenotypic features, involving somatic mutations of BRAF and activation of MAPK pathway. Other BRAF mutated neoplasms such as papillary thyroid carcinoma (PTC), may also occur synchronous with EDC. There are several reports in the literature of concurrent Langerhans Cell Histiocytosis (LCH) and PTC which suggests that the association is not random, howeve...

ea0092ps3-28-06 | Translational 2 | ETA2023

Next-generation-sequencing on fine needle aspirates in neck recurrence of thyroid cancers

Theodon Helene , Buffet Camille , Guillerm Erell , Wasserman Johanna , Deniziaut Gabrielle , Jaffrelot Loic , Denis Jerome , Chereau Nathalie , Bigorgne Claude , Potonnier Wiame , Coulet Florence , Leenhardt Laurence

Objectives: Tumor molecular genotyping plays a key role in improving the management of advanced thyroid cancers. Molecular tests are classically performed on Formalin-Fixed Paraffin-Embedded (FFPE) carcinoma tissue. However alternative molecular testing strategies are needed when FFPE tumoral tissue is unavailable. The objective of our study was to retrospectively assess the performance of targeted DNA and RNA-based Next Generation Sequencing (NGS) on the fine needle aspirate ...